首页> 外文期刊>Diabetes >Insulin Resistance and Vulnerability to Cardiac Ischemia
【24h】

Insulin Resistance and Vulnerability to Cardiac Ischemia

机译:胰岛素抵抗和对心脏缺血的脆弱性

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatic and myocardial ectopic lipid deposition has been associated with insulin resistance (IR) and cardiovascular risk. Lipid overload promotes increased hepatic oxidative capacity, oxidative stress, and impaired mitochondrial efficiency, driving the progression of nonalcoholic fatty liver disease (NAFLD). We hypothesized that higher lipid availability promotes ischemia-induced cardiac dysfunction and decreases myocardial mitochondrial efficiency. Mice with adipose tissue-specific overexpression of sterol element-binding protein 1 c as model of lipid overload with combined NAFLD-IR and controls underwent reperfused acute myocardial infarcts (AMIs). Whereas indexes of left ventricle (LV) contraction were similar in both groups at baseline, NAFLD-IR showed severe myocardial dysfunction post-AMI, with prominent LV reshaping and increased end-diastolic and end-systolic volumes. Hearts of NAFLD-IR displayed hypertrophy, steatosis, and IR due to 18:1/18:1 -diacylglycerol-mediated protein kinase Ce (PKCe) activation. Myocardial fatty acid-linked respiration and oxidative stress were increased, whereas mitochondrial efficiency was decreased. In humans, decreased myocardial mitochondrial efficiency of ventricle biopsies related to IR and troponin levels, a marker of impaired myocardial integrity. Taken together, increased lipid availability and IR favor susceptibility to ischemia-induced cardiac dysfunction. The diacylgly-cerol-PKCe pathway and reduced mitochondrial efficiency both caused by myocardial lipotoxicity may contribute to the impaired LV compensation of the noninfarcted region of the myocardium.
机译:肝和心肌异位脂质沉积已与胰岛素抵抗(IR)和心血管风险相关。脂质超载促进肝脏氧化能力的增强,氧化应激和线粒体效率的损害,从而推动非酒精性脂肪肝疾病(NAFLD)的发展。我们假设较高的脂质利用率促进局部缺血引起的心脏功能障碍,并降低心肌线粒体效率。脂肪组织特异性过表达固醇元素结合蛋白1 c的小鼠作为脂质超负荷的模型,与NAFLD-IR和对照组合用,进行了再灌注的急性心肌梗塞(AMI)。两组在基线时左心室(LV)的收缩指标相似,但NAFLD-IR显示严重的AMI后心肌功能障碍,伴有明显的LV重塑以及舒张末期和收缩末期容积增加。由于18:1/18:1-二酰甘油介导的蛋白激酶Ce(PKCe)活化,NAFLD-IR的心脏显示出肥大,脂肪变性和IR。心肌脂肪酸相关的呼吸作用和氧化应激增加,而线粒体效率降低。在人类中,与IR和肌钙蛋白水平有关的心室活检心肌线粒体效率降低,这是心肌完整性受损的标志。两者合计,增加的脂质利用率和IR有利于缺血引起的心脏功能障碍的易感性。心肌脂毒性引起的双酰基-甘油-PKCe途径和线粒体效率的降低均可能导致心肌非梗死区域的左室代偿功能受损。

著录项

  • 来源
    《Diabetes》 |2018年第12期|2695-2702|共8页
  • 作者单位

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany;

    Department of Molecular Cardiology, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Department of Molecular Cardiology, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany;

    German Center for Diabetes Research, Munchen-Neuherberg, Germany,Institute for Biochemistry and Pathobiochemistry, German Diabetes Center, Duesseldorf, Germany;

    German Center for Diabetes Research, Munchen-Neuherberg, Germany,Institute for Biochemistry and Pathobiochemistry, German Diabetes Center, Duesseldorf, Germany;

    Department of Medicine I, University Hospital Aachen, Aachen, Germany;

    Department of Cardiovascular Physiology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Department of Cardiovascular Physiology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany,Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

    Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany,German Center for Diabetes Research, Munchen-Neuherberg, Germany,Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 04:08:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号